{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:45:48Z","timestamp":1775007948980,"version":"3.50.1"},"reference-count":0,"publisher":"Archives of Pathology and Laboratory Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Embryonal carcinoma (ECA) of the ovary is rare, particularly in pure form, with very limited available information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To expand on knowledge by reviewing our experience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>We report 55 tumors with an ECA component in patients from ages 3 to 57 years (median, 20.5 years), with emphasis on their pathologic features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>The tumors ranged from 2.5 to 31 cm (average, 15.4 cm), being predominantly solid and cystic with hemorrhagic necrosis. In all cases, the ECA was a component of a malignant mixed germ cell tumor (MMGCT) and represented less than 15% in 22 tumors (40%), 16% to 50% in 22 (40%), 51% to 75% in 6 (11%), and greater than 75% in 5 (9%). Components admixed with the ECA included yolk sac tumor (n = 49; 89%), immature teratoma (n = 34; 62%), dysgerminoma (n = 20; 36%), and choriocarcinoma (n = 5; 9%). The most common microscopic patterns of the ECA were glandular (n = 24; 45%), solid (n = 19; 35%), papillary (n = 5; 9%), and micropapillary (n = 1; 2%). Embryoid bodies, or remnants thereof, were present in 16 tumors (29%), and 6 (11%) had a diffuse embryoma pattern. Apoptotic bodies were commonly found. A lymphocytic infiltrate and granulomas were seen in 25 tumors (45%) and in 4 tumors (7%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Pure ovarian ECA is rare; none were identified in our series. Many purported pure examples are likely undersampled MMGCTs or other tumor types (yolk sac tumor, dysgerminoma [particularly when poorly fixed], small cell carcinoma of hypercalcemic type, juvenile granulosa cell tumor, and high-grade surface epithelial carcinomas). The diagnosis can be made on the basis of morphologic criteria and, in problematic cases, supported by immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2025-0482-oa","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:33:19Z","timestamp":1775003599000},"source":"Crossref","is-referenced-by-count":0,"title":["Embryonal Carcinoma Involving the Ovary: A Morphologic Study of 55 Tumors Almost Never Pure, But Common Within Malignant Mixed Germ Cell Tumors"],"prefix":"10.5858","author":[{"given":"Valentina","family":"Zanfagnin","sequence":"first","affiliation":[{"name":"From the James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[{"name":"From the James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Young","sequence":"additional","affiliation":[{"name":"From the James Homer Wright Pathology Laboratories, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/aop\/article-10.5858-arpa.2025-0482-OA\/article-10.5858-arpa.2025-0482-OA.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/aop\/article-10.5858-arpa.2025-0482-OA\/article-10.5858-arpa.2025-0482-OA.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/aop\/article-10.5858-arpa.2025-0482-OA\/article-10.5858-arpa.2025-0482-OA.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:33:19Z","timestamp":1775003599000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/aop\/article-10.5858-arpa.2025-0482-OA\/article-10.5858-arpa.2025-0482-OA.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":0,"URL":"https:\/\/doi.org\/10.5858\/arpa.2025-0482-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,26]]}}}